Literature DB >> 10390327

Which targets are relevant for therapy of acute ischemic stroke?

W D Heiss1, A Thiel, M Grond, R Graf.   

Abstract

BACKGROUND: The efficiency of various strategies of neuroprotection is well documented in animal experiments but is thus far disappointing in ischemic stroke, for which only early reperfusion induced by thrombolysis has improved clinical outcome. This discrepancy between expectation from experimental research and clinical reality may be related to differences in the pathogenetic factors contributing to infarction. SUMMARY OF COMMENT: Positron emission tomography cerebral blood flow studies within 3 hours of onset were used to identify the various compartments of the infarct outlined on MRI 2 to 3 weeks after a hemispheric stroke in 10 patients. Critical hypoperfusion below the viability threshold accounted for the largest proportion (mean, 70%) of the final infarct, whereas penumbral tissue (18%) and initially sufficiently perfused tissue (12%) were responsible for considerably smaller portions of the final infarct.
CONCLUSIONS: These results indicate that early critical flow disturbance leading to rapid cell damage is the predominant cause of infarction, while secondary and delayed pathobiochemical processes in borderline or initially sufficiently perfused regions contribute only little to the final infarct. Therefore, emerging therapeutic strategies should be targeted to the initially critically perfused tissue subcompartments. Clinical drug trials might benefit from stratification of patients for target tissue compartments applying functional imaging.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10390327     DOI: 10.1161/01.str.30.7.1486

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  17 in total

Review 1.  Neuroprotective agents for the treatment of acute ischemic stroke.

Authors:  Bruce Ovbiagele; Chelsea S Kidwell; Sidney Starkman; Jeffrey L Saver
Journal:  Curr Neurol Neurosci Rep       Date:  2003-01       Impact factor: 5.081

Review 2.  Preclinical drug evaluation for combination therapy in acute stroke using systematic review, meta-analysis, and subsequent experimental testing.

Authors:  Victoria E O'Collins; Malcolm R Macleod; Susan F Cox; Leena Van Raay; Elena Aleksoska; Geoffrey A Donnan; David W Howells
Journal:  J Cereb Blood Flow Metab       Date:  2010-10-27       Impact factor: 6.200

3.  Whole-brain arterial spin labeling perfusion MRI in patients with acute stroke.

Authors:  Reinoud P H Bokkers; Daymara A Hernandez; José G Merino; Raymond V Mirasol; Matthias J van Osch; Jeroen Hendrikse; Steven Warach; Lawrence L Latour
Journal:  Stroke       Date:  2012-03-15       Impact factor: 7.914

Review 4.  Protective Effects of Curcumin Against Ischemia-Reperfusion Injury in the Nervous System.

Authors:  Kowsar Bavarsad; George E Barreto; Mousa-Al-Reza Hadjzadeh; Amirhossein Sahebkar
Journal:  Mol Neurobiol       Date:  2018-06-09       Impact factor: 5.590

5.  Pseudocontinuous arterial spin labeling quantifies relative cerebral blood flow in acute stroke.

Authors:  Daymara A Hernandez; Reinoud P H Bokkers; Raymond V Mirasol; Marie Luby; Erica C Henning; José G Merino; Steven Warach; Lawrence L Latour
Journal:  Stroke       Date:  2012-02-16       Impact factor: 7.914

Review 6.  Brain tissue salvage in acute stroke.

Authors:  Perttu J Lindsberg
Journal:  Neurocrit Care       Date:  2004       Impact factor: 3.210

Review 7.  Therapeutic potential of platelet glycoprotein IIb/IIIa receptor antagonists in acute ischaemic stroke: scientific rationale and available evidence.

Authors:  Arthur M Pancioli; Thomas G Brott
Journal:  CNS Drugs       Date:  2004       Impact factor: 5.749

Review 8.  Can the time window for administration of thrombolytics in stroke be increased?

Authors:  Geoffrey A Donnan; David W Howells; Romesh Markus; Danilo Toni; Stephen M Davis
Journal:  CNS Drugs       Date:  2003       Impact factor: 5.749

Review 9.  Ischemic tolerance in stroke treatment.

Authors:  Nora Sandu; Jan Cornelius; Andreas Filis; Belachew Arasho; Miguel Perez-Pinzon; Bernhard Schaller
Journal:  Expert Rev Cardiovasc Ther       Date:  2009-10

10.  Protective effects of Lycium barbarum polysaccharide on neonatal rat primary cultured hippocampal neurons injured by oxygen-glucose deprivation and reperfusion.

Authors:  Chen Rui; Li Yuxiang; Hao Yinju; Zhu Qingluan; Wu Yang; Zhao Qipeng; Wang Hao; Ma Lin; Liu Juan; Zhao Chengjun; Jiang Yuanxu; Wang Yanrong; Dai Xiuying; Zhang Wannian; Sun Tao; Yu Jianqiang
Journal:  J Mol Histol       Date:  2012-05-05       Impact factor: 2.611

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.